MigraSpray

MigraSpray™

An over-the-counter nutraceutical containing feverfew (Tanacetum parthenium), a herb which is allegedly useful for treating headaches.
References in periodicals archive ?
MIGRASPRAY is a patented spray formulation, delivered sublingually, containing the herb feverfew, intended to provide fast relief and prevention from pain and other symptoms associated with migraine headaches.
The magazine's editors have awarded MIGRASPRAY with the "Editor's Choice" stamp, which is only given to products that Natural Health identifies as meriting special attention.
Not only does MigraSpray not contribute to rebound headaches, but it can even be used every day for prevention of migraine without sensitizing pain receptors or causing gastro-intestinal problems.
Jim Arabia, Chairman and CEO of the Company said, "This is a great development for the Company regarding its goal of raising awareness about MigraSpray.
Jim Arabia, Chairman and CEO of the Company said, "We're very pleased that MIGRASPRAY will be exclusively marketed on the Company's behalf by Morgan & Sampson Pacific.
Such broadcasts, together with the Company's print and television advertising, should increase consumer awareness, product branding and retail sales of MIGRASPRAY.
Jim Arabia, Chairman and CEO of the Company said, "We're very pleased that MIGRASPRAY will be carried in another large national retailer such as Rite Aid.
These well known doctors will make excellent representatives for MIGRASPRAY on future television and radio broadcasts to promote the product and will add credibility to MIGRASPRAY'S use and effectiveness.
Pescatore, a national spokesperson for MIGRASPRAY, discusses MIGRASPRAY'S efficacy and clinically proven ability to provide fast relief from pain and other symptoms associated with migraine headaches.
With the addition of CVS, MIGRASPRAY will soon be in over 10,000 stores nationally, reaching nearly every corner of the United States.
We are confident that Media Relations is the right choice to promote and generate consumer awareness and excitement for our highly effective migraine relief product, MigraSpray.
The clinical trial concluded that the efficacy of MigraSpray(TM) was clearly demonstrated and the average time to relief for the MigraSpray Group was just over six minutes.